CE: Maximizing the effectiveness of influenza and other vaccines for older adults

Vaccinations against influenza, pneumococcal disease, COVID-19 and shingles are recommended for older adults due to the disproportionately high burden of illness borne by this population. As well, the first vaccine to protect against RSV infection in older adults recently became available in Canada. 

This accredited on-demand webinar will help you navigate the growing number of recommended vaccines for older adults, with a focus on influenza. 

Supported by an unrestricted education grant from CSL Seqirus.

Learning objectives
 

• Review the changing epidemiology of influenza, particularly regarding A strains, the primary causes of disease burden in older adults and the concept of vaccine cross-protection in the B strain. 
• Discuss the relevance and evidence of real-world effectiveness of influenza vaccines, recent global influenza guidelines and public programs targeted at older adults. 
• Explain the importance of the seasonal influenza vaccine in the context of other vaccines recommended for older adults, emphasizing the specific benefits, risks and other considerations. 
• Evaluate and discuss the safety, efficacy and practical considerations of co-administering the influenza vaccine with other vaccines, in the context of older adults and varying immunization schedules.

Course author: Victor Wong, RPh, PharmD, MBA, MFIN; with moderator Betty Gloightly, RPh, B.Sc.Pharm, FTM RC{S (Glasg), CTH

This continuing education is free for members of CanadianHealthcareNetwork.ca. Log in and click here to take the course: